IT1131854B - PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC USE, FOR DIAGNOSTIC USE AND AS A FOOD SUPPLEMENT - Google Patents

PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC USE, FOR DIAGNOSTIC USE AND AS A FOOD SUPPLEMENT

Info

Publication number
IT1131854B
IT1131854B IT23101/80A IT2310180A IT1131854B IT 1131854 B IT1131854 B IT 1131854B IT 23101/80 A IT23101/80 A IT 23101/80A IT 2310180 A IT2310180 A IT 2310180A IT 1131854 B IT1131854 B IT 1131854B
Authority
IT
Italy
Prior art keywords
pharmaceutical composition
food supplement
diagnostic
therapeutic use
therapeutic
Prior art date
Application number
IT23101/80A
Other languages
Italian (it)
Other versions
IT8023101A0 (en
Inventor
Massimo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Publication of IT8023101A0 publication Critical patent/IT8023101A0/en
Priority to IT23101/80A priority Critical patent/IT1131854B/en
Priority to GB8110839A priority patent/GB2078516B/en
Priority to DE19813115322 priority patent/DE3115322A1/en
Priority to JP5725381A priority patent/JPS5714530A/en
Priority to FR8110280A priority patent/FR2485371A1/en
Priority to CH4268/81A priority patent/CH649222A5/en
Priority to AU72336/81A priority patent/AU560450B2/en
Priority to PT73286A priority patent/PT73286B/en
Priority to ZA814430A priority patent/ZA814430B/en
Application granted granted Critical
Publication of IT1131854B publication Critical patent/IT1131854B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT23101/80A 1980-06-30 1980-06-30 PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC USE, FOR DIAGNOSTIC USE AND AS A FOOD SUPPLEMENT IT1131854B (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT23101/80A IT1131854B (en) 1980-06-30 1980-06-30 PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC USE, FOR DIAGNOSTIC USE AND AS A FOOD SUPPLEMENT
GB8110839A GB2078516B (en) 1980-06-30 1981-04-07 Pharmaceutical compositions containing arginine and lysine
DE19813115322 DE3115322A1 (en) 1980-06-30 1981-04-15 PHARMACEUTICAL OR. DIAGNOSTICALLY OR AS A FOOD ADDITIVE EFFECTIVE OR APPLICABLE AGENT
JP5725381A JPS5714530A (en) 1980-06-30 1981-04-17 Pharmaceutic composition useful for treatment and diagnosis and feed regulant
FR8110280A FR2485371A1 (en) 1980-06-30 1981-05-22 NOVEL COMPOSITION FOR THERAPEUTIC USE BASED ON LYSINE AND ARGININE
CH4268/81A CH649222A5 (en) 1980-06-30 1981-06-29 PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC USE, FOR DIAGNOSTIC USE AND AS A FOOD SUPPLEMENT.
AU72336/81A AU560450B2 (en) 1980-06-30 1981-06-29 Compositions of arginine and lysine
PT73286A PT73286B (en) 1980-06-30 1981-06-29 Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator
ZA814430A ZA814430B (en) 1980-06-30 1981-06-30 Pharmaceutical composition for therapeutical and diagnostic use and useful as feed integrator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23101/80A IT1131854B (en) 1980-06-30 1980-06-30 PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC USE, FOR DIAGNOSTIC USE AND AS A FOOD SUPPLEMENT

Publications (2)

Publication Number Publication Date
IT8023101A0 IT8023101A0 (en) 1980-06-30
IT1131854B true IT1131854B (en) 1986-06-25

Family

ID=11203787

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23101/80A IT1131854B (en) 1980-06-30 1980-06-30 PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC USE, FOR DIAGNOSTIC USE AND AS A FOOD SUPPLEMENT

Country Status (9)

Country Link
JP (1) JPS5714530A (en)
AU (1) AU560450B2 (en)
CH (1) CH649222A5 (en)
DE (1) DE3115322A1 (en)
FR (1) FR2485371A1 (en)
GB (1) GB2078516B (en)
IT (1) IT1131854B (en)
PT (1) PT73286B (en)
ZA (1) ZA814430B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314079A1 (en) * 1982-04-19 1983-12-22 Papst Motoren Gmbh & Co Kg Multi-shaft mechanism for signal carriers in cassette form
DE3242501C1 (en) * 1982-11-18 1984-03-29 Degussa Ag, 6000 Frankfurt Use of aqueous L-lysine solutions to supplement feed with L-lysine
FR2568124B1 (en) * 1984-07-24 1988-12-09 Cortial MEDICINE FOR TREATING HYPOTROPHIC CONDITIONS BY ADMINISTRATION OF ARGININE ASPARTATE
US5077313A (en) * 1988-11-25 1991-12-31 Gert Lubec Process for inhibiting pathological collagen cross-linking in diabetes patients
AT393079B (en) * 1989-03-06 1991-08-12 Lubec Gert Pharmaceutical use of agmatine
AT393080B (en) * 1988-11-25 1991-08-12 Lubec Gert Pharmaceutical use of arginine (salts)
US6143786A (en) * 1999-02-02 2000-11-07 Novartis Nutrition Ag Oral arginine and insulin secretion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6588M (en) * 1967-10-11 1968-12-30

Also Published As

Publication number Publication date
CH649222A5 (en) 1985-05-15
PT73286A (en) 1981-07-01
AU560450B2 (en) 1987-04-09
GB2078516A (en) 1982-01-13
GB2078516B (en) 1985-02-27
AU7233681A (en) 1982-01-14
FR2485371A1 (en) 1981-12-31
ZA814430B (en) 1982-09-29
PT73286B (en) 1982-07-22
JPS5714530A (en) 1982-01-25
IT8023101A0 (en) 1980-06-30
FR2485371B1 (en) 1985-04-12
DE3115322A1 (en) 1982-04-08

Similar Documents

Publication Publication Date Title
DE3175083D1 (en) Pharmaceutical compounds, their preparation and use
IL55183A0 (en) Novel imidazoquinazoline derivatives, their preparation and pharmaceutical compositions containing them
IL54842A (en) 1-piperidino-phthalazine derivatives,their preparation and pharmaceutical compositions containing them
FI830163A7 (en) Phenylethylene derivatives, their preparation and use as pharmaceuticals.
DE3167679D1 (en) Pharmaceutical forms, their preparation and compositions containing the same
IL54337A (en) 1-aminoindanes, their preparation and pharmaceutical compositions comprising them
IL60918A0 (en) 6-pyridayinones,their preparation and pharmaceutical compositions cosntaining them
IL55765A (en) Dehydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL56248A (en) 4-spectinomycylamine and salts thereof,their preparation and pharmaceutical compositions containing them
IL54535A0 (en) Novel -lactam derivatives, their preparation and pharmaceutical compositions containing them
IL62824A (en) Phthalyltaurine derivatives,their preparation and pharmaceutical compositions comprising them
IL61700A (en) Analgesic tetrapeptides,their preparation and pharmaceutical compositions comprising them
IL61702A (en) Anagesic tetrapeptides,their preparation and pharmaceutical compositions comprising them
IT1131854B (en) PHARMACEUTICAL COMPOSITION FOR THERAPEUTIC USE, FOR DIAGNOSTIC USE AND AS A FOOD SUPPLEMENT
DE2860410D1 (en) 2-piperazinotetraline derivatives, their preparation and their use as medicines
IL53766A0 (en) 4-diphenylmethylene-1-hydroxybenzyl-piperidine derivatives, their preparation and pharmaceutical compositions containing them
FI821288A7 (en) Phenethanolamine derivatives, their preparation and their therapeutic use.
IL55857A (en) Benzodioxanylcarbonyl-piperazinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
PH15625A (en) Pyridazopyridazine derivatives,their pharmaceutical compositions and their use
IL54899A (en) Pyridazinylhydrazones,their preparation and pharmaceutical compositions containing them
DE2862077D1 (en) Acylhydrocarbylaminoalcanecarboxylic acids, their preparation and their use, and pharmaceutical compositions containing them
IL62400A0 (en) Thiazole derivatives,their preparation and pharmaceutical compositions containing them
IL56021A (en) 2-heterocyclylalklyl-6-methoxy-naphathalenes,their preparation and pharmaceutical compositions containing them
IL54001A0 (en) 2,4-dichlorophenyl-imidazolyl-ethan-ones and -ols, their preparation and pharmaceutical compositions containing the
IL54284A0 (en) Non-glycosidic theophylline-sugar derivatives, their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970627